West Malinda T, Tamba Gagah P, Thawani Rajat, Drew Antonene, Wilde Nicole V, Graff Julie N, Mannino Rosemarie
Veterans Affairs Portland Health Care System, Oregon.
Knight Cancer Institute, Oregon Health and Science University, Portland.
Fed Pract. 2022 Aug;39(Suppl 3):e0292. doi: 10.12788/fp.0292. Epub 2022 Aug 24.
Our objective was to explore whether differences in patient satisfaction based on gender exist at the Veterans Affairs Portland Health Care System (VAPHCS) outpatient chemotherapy infusion unit.
Veterans who received outpatient infusion treatments at the VAPHCS outpatient chemotherapy infusion unit from 2018 to 2020 were invited to take an anonymous survey. Response differences were analyzed using Fisher exact and Welch tests. Male and female patient lists were first generated based on Computerized Patient Record System designation, then defined and results reported based on gender self-identification from survey responses.
The survey was conducted over a 2-week period during January and February of 2021. In total, 69 veterans were contacted: 21 (70%) of 30 female and 20 (51%) of 39 male veterans completed the survey. Most (62%) female patients were aged < 65 years, and 52% were treated for breast cancer. Most (90%) male patients were aged ≥ 65 years, and most commonly treated for prostate cancer (20%) or a hematologic malignancy (20%). Using our survey, patient satisfaction (SD) was 8.7 (2.2) on a 10-point scale among women, and 9.6 (0.6) among men ( = .11). History of sexual abuse or harassment was reported by 86% of women compared with 10% of men ( < .001). Women reported feeling uncomfortable around other patients in the infusion unit compared with men (29% vs 0%; = .02) and discomfort in relaying uncomfortable feelings to a clinician (29% vs 0%; = .02).
Gender seems to be related to how veterans with cancer perceive their ambulatory cancer care. This may be due to the combination of a high history of sexual abuse and/or harassment among women who represent a minority of the total infusion unit population, the majority of whom receive treatment for a primarily gender-specific breast malignancy. Analysis was limited by the small sample size of women, many with advanced malignancy.
我们的目标是探讨波特兰退伍军人事务部医疗保健系统(VAPHCS)门诊化疗输液单元中基于性别的患者满意度差异是否存在。
邀请2018年至2020年期间在VAPHCS门诊化疗输液单元接受门诊输液治疗的退伍军人参加匿名调查。使用Fisher精确检验和Welch检验分析应答差异。首先根据计算机化患者记录系统的指定生成男性和女性患者名单,然后根据调查应答中的性别自我认同进行定义并报告结果。
调查于2021年1月和2月的两周内进行。总共联系了69名退伍军人:30名女性退伍军人中有21名(70%)、39名男性退伍军人中有20名(51%)完成了调查。大多数(62%)女性患者年龄小于65岁,52%接受乳腺癌治疗。大多数(90%)男性患者年龄≥65岁,最常见的治疗疾病为前列腺癌(20%)或血液系统恶性肿瘤(20%)。根据我们的调查,女性患者的满意度(标准差)在10分制中为8.7(2.2),男性为9.6(0.6)(P = 0.11)。86%的女性报告有性虐待或骚扰史,而男性为10%(P < 0.001)。与男性相比,女性报告在输液单元中与其他患者在一起时感到不舒服(29%对0%;P = 0.02),以及向临床医生传达不舒服感受时感到不适(29%对0%;P = 0.02)。
性别似乎与患癌退伍军人对其门诊癌症护理的认知方式有关。这可能是由于在占输液单元总人口少数的女性中,性虐待和/或骚扰史较高,其中大多数接受主要针对特定性别的乳腺恶性肿瘤的治疗。分析受到女性样本量小且许多患有晚期恶性肿瘤的限制。